Cargando…
PRMT1, a Key Modulator of Unliganded Progesterone Receptor Signaling in Breast Cancer
The progesterone receptor (PR) is a key player in major physiological and pathological responses in women, and the signaling pathways triggered following hormone binding have been extensively studied, particularly with respect to breast cancer development and progression. Interestingly, growing evid...
Autores principales: | Malbeteau, Lucie, Jacquemetton, Julien, Languilaire, Cécile, Corbo, Laura, Le Romancer, Muriel, Poulard, Coralie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455263/ https://www.ncbi.nlm.nih.gov/pubmed/36076907 http://dx.doi.org/10.3390/ijms23179509 |
Ejemplares similares
-
PRMT1 Is Critical for the Transcriptional Activity and the Stability of the Progesterone Receptor
por: Malbeteau, Lucie, et al.
Publicado: (2020) -
PRMT5 prognostic value in cancer
por: Lattouf, Hanine, et al.
Publicado: (2019) -
ERα-36 regulates progesterone receptor activity in breast cancer
por: Konan, Henri-Philippe, et al.
Publicado: (2020) -
Structure, Activity, and Function of PRMT1
por: Thiebaut, Charlène, et al.
Publicado: (2021) -
Nuclear PRMT5 is a biomarker of sensitivity to tamoxifen in ERα
(+) breast cancer
por: Poulard, Coralie, et al.
Publicado: (2023)